Loading clinical trials...
Loading clinical trials...
The Efficacy of Intravenous Hydroxocobalamin Versus Methylene Blue as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
Conditions
Interventions
Hydroxocobalamin
Methylene Blue
Locations
1
United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Start Date
November 30, 2019
Primary Completion Date
February 27, 2023
Completion Date
February 27, 2024
Last Updated
June 24, 2024
NCT06169592
NCT06048445
NCT06060392
NCT06934798
NCT06539234
NCT05081141
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions